The Lynx Group

2022 Midyear Review: NSCLC

2022 Midyear Review: Non–Small-Cell Lung Cancer

We are pleased to provide highlights of important and potentially practice-changing developments in immunotherapy of non–small-cell lung cancer (NSCLC) presented at the 2022 annual meetings of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). In this print supplement, we will summarize pivotal clinical [ Read More ]

Sign me up!